close

Enter

Log in using OpenID

Autism Spectrum Disorder Therapeutics Market - Size, Share, Outlook

embed
Autism Spectrum Disorder (ASD) is a neurodegenerative disorder, which is associated and often overlaps with other conditions such as epilepsy, frequent infections, sleep disorders, anxiety, depression, and gastrointestinal problems. ASD is only diag
Autism Spectrum Disorder Therapeutics
Market
GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Autism Spectrum Disorder Therapeutics Market – Overview
Autism Spectrum Disorder (ASD) is a neurodegenerative disorder, which is associated and often overlaps
with other conditions such as epilepsy, frequent infections, sleep disorders, anxiety, depression, and
gastrointestinal problems. ASD is only diagnosed by developmental and comprehensive tests. It can be
detected at eighteen months to two years of age. Drugs such as Aripiprazole, Risperidone, and Melatonin
are U.S. Food and Drug Administration (FDA) approved drugs that aid in the treatment of ASD.
Bumetanide and Balovaptan are the drugs that are under clinical trial and investigation to evaluate their
safety and efficacy for the treatment of ASD.
The global autism spectrum disorder therapeutics (ASD) therapeutics market size was valued at US$
2,169.3 million in 2018, and is expected to witness a CAGR of 6.8% over the forecast period (2018 –
2026).
REPORT DESCRIPTION
Autism Spectrum Disorder Therapeutics Market – Dynamics
Increasing prevalence of ASD worldwide is expected to boost the Autism Spectrum Disorder Therapeutics
(ASD) therapeutics market growth. For instance, according to the data published in Our World in Data in
2017, around 62 million people worldwide were estimated to have ASD in 2016. Moreover, under 50
million of these cases were found in males. Of this 62 million with ASD, around 18 million had only
Autism and 44 million had Asperger syndrome and other spectrum disorders.
However, stringent regulations and continuous watch employed by governing authorities for product
approval and marketing of medicines can act as a potential hindrance for growth of the autism spectrum
disorder therapeutics market. For instance, in May 2017, the U.S. Food and Drug Administration (FDA)
shut down operations of Louisiana-based Pick and Pay Inc. / Cili Minerals, a manufacturer of drug and
dietary supplements, after finding that the company was falsely marketing products as being able to treat
autism.
Download PDF Brochure @
https://www.coherentmarketinsights.com/insight/request-pdf/2643
REPORT DESCRIPTION
Autism Spectrum Disorder Therapeutics Market – Key Players
•
•
•
•
•
•
•
•
•
F. Hoffmann-La Roche AG
Neurim Pharmaceuticals, Inc.
Yamo Pharmaceuticals LLC
Servier Laboratories Ltd.
Otsuka Holdings Co. Ltd.
Curemark LLC
Oryzon Genomics S.A.
GW Pharmaceuticals Plc.
Teva Pharmaceutical Industries
Read More @
https://www.coherentmarketinsights.com/market-insight/autism-spectrum-disorder-therapeutics-market-2643
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
MEDICAL DEVICES




CLINICAL
DIAGNOSTIC
MEDICAL IMAGING
Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
 Private and Government organization
 Outsourcing Companies
 Universities and Business Schools.
HEALTHCARE IT
PHARMACEUTICAL
ABOUT US
KEY STATS
100
+
150+
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
Insights Published Per Year
Consulting Projects Till
Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
Author
sujit Pawar
sujit Pawar76   documents Email
Document
Category
Health and Medicine
Views
2
File Size
448 KB
Tags
therapeutics
1/--pages
Report inappropriate content